Published in Klin Wochenschr on February 04, 1985
The gut microbiota--masters of host development and physiology. Nat Rev Microbiol (2013) 5.25
The intestinal microbiota and chronic disorders of the gut. Nat Rev Gastroenterol Hepatol (2011) 1.86
Deoxycholic acid activates beta-catenin signaling pathway and increases colon cell cancer growth and invasiveness. Mol Biol Cell (2004) 1.22
The bile acid nuclear receptor FXR and the bile acid binding protein IBABP are differently expressed in colon cancer. Dig Dis Sci (2004) 1.14
Differential effects of deoxycholic acid on proliferation of neoplastic and differentiated colonocytes in vitro. Dig Dis Sci (1997) 0.80
Effect of Wheat Dietary Fiber Particle Size during Digestion In Vitro on Bile Acid, Faecal Bacteria and Short-Chain Fatty Acid Content. Plant Foods Hum Nutr (2016) 0.75
European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. Gastroenterology (1984) 4.09
Proton-pump inhibitors or H2-receptor antagonists for Helicobacter pylori eradication-a meta-analysis. Lancet (1996) 2.65
A comparison of budesonide with prednisolone for active Crohn's disease. N Engl J Med (1994) 2.58
[Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons]. Z Gastroenterol (1996) 2.04
[Consensus report: irritable bowel syndrome--definition, differential diagnosis, pathophysiology and therapeutic possibilities. Consensus of the German Society of Digestive and Metabolic Diseases]. Z Gastroenterol (1999) 1.43
Enhanced formation of sulfidopeptide-leukotrienes in ulcerative colitis and Crohn's disease: inhibition by sulfasalazine and 5-aminosalicylic acid. Agents Actions (1986) 1.29
Helicobacter pylori and the risk of colonic adenomas. Colorectal Adenoma Study Group. Digestion (1999) 1.29
Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regul Pept (1994) 1.25
Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study. Gut (1996) 1.25
Altered vagal and intestinal mechanosensory function in chronic unexplained dyspepsia. Gut (1998) 1.21
Ileal release of glucagon-like peptide-1 (GLP-1). Association with inhibition of gastric acid secretion in humans. Dig Dis Sci (1995) 1.18
Treatment of acute viral hepatitis with (+)-cyanidanol-3. Lancet (1977) 1.18
Modulation of intestinal epithelial wound healing in vitro and in vivo by lysophosphatidic acid. Gastroenterology (1999) 1.16
Prokinetics in patients with gastroparesis: a systematic analysis. Digestion (1999) 1.16
Fructose induced depletion of liver adenine nucleotides in man. Horm Metab Res (1971) 1.15
[Elimination of errors caused by turbidity in the determination of protein by the biuret method]. Z Klin Chem Klin Biochem (1968) 1.14
(+)-Cyanidanol-3 in the treatment of acute viral hepatitis: a randomized controlled trial. Hepatology (1984) 1.12
Functional dyspepsia and irritable bowel syndrome: is there a common pathophysiological basis? Am J Gastroenterol (1997) 1.11
Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trial. J Clin Oncol (1996) 1.09
[Diagnostic possibilities with the determination of amylase and lipase in body fluids]. Internist (Berl) (1970) 1.08
Dyspepsia in healthy blood donors. Pattern of symptoms and association with Helicobacter pylori. Dig Dis Sci (1994) 1.06
Cholecystokinin-58 is the major circulating form of cholecystokinin in canine blood. J Biol Chem (1987) 1.06
Effect of cigarette smoking on the course of Crohn's disease. Eur J Gastroenterol Hepatol (1996) 1.03
Action of ethanol and some alcoholic beverages on gastric acid secretion and release of gastrin in humans. Gastroenterology (1987) 1.03
Impaired small intestinal peristaltic reflexes and sensory thresholds are independent functional disturbances in patients with chronic unexplained dyspepsia. Am J Gastroenterol (1996) 1.00
Human pancreatic secretion and intestinal motility: effects of ileal nutrient perfusion. Am J Physiol (1990) 0.99
[Influence of secretin and pancreozymin on secretion of calcium in the human duodenal juice in normal and impaired pancreas function]. Klin Wochenschr (1970) 0.99
Action of atropine on the pancreatic secretory response to secretin before and after cutting the extrinsic nerves of the pancreas in dogs. Gastroenterology (1986) 0.98
Genetic factors determine extent of bone loss in inflammatory bowel disease. Gastroenterology (2000) 0.97
Effect of atropine on pancreatic response to HCl and secretin. Am J Physiol (1981) 0.97
Effects of exogenous zinc supplementation on intestinal epithelial repair in vitro. Eur J Clin Invest (2000) 0.97
Adenine nucleotides modulate epithelial wound healing in vitro. Eur J Clin Invest (1998) 0.96
A new molecular form of PYY: structural characterization of human PYY(3-36) and PYY(1-36). Peptides (1989) 0.96
Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis. Eur J Clin Pharmacol (1985) 0.96
Epidemiology of gallstones in a German industrial town (Essen) from 1940-1975. Digestion (1986) 0.95
The role of calcium in pancreatic secretion and disease. Acta Hepatogastroenterol (Stuttg) (1976) 0.93
Oral contraceptive use and cigarette smoking in Crohn's disease. Dig Dis Sci (1993) 0.93
Somatostatin 28 and coupling of human interdigestive intestinal motility and pancreatic secretion. Gastroenterology (1992) 0.92
Persistent inhibition of gastric secretion by an intravenous 12-hour infusion of calcitonin in normals, peptic ulcer and high risk patients. Digestion (1974) 0.92
Time trends in the incidence and disease location of Crohn's disease 1980-1995: a prospective analysis in an urban population in Germany. Inflamm Bowel Dis (1999) 0.92
Association between H. pylori, duodenal mechanosensory thresholds, and small intestinal motility in chronic unexplained dyspepsia. Dig Dis Sci (1996) 0.91
Parallel secretion of calcium and enzymes by the human pancreas. Digestion (1973) 0.91
Stimulatory effect of pancreozymin-cholecystokinin on calcium secretion in pancreatic juice of dogs. Gut (1972) 0.90
Inhibition of gastric secretion in man by oral administration of calcitonin. Digestion (1974) 0.90
Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease. Inflamm Bowel Dis (1998) 0.90
A double-blind trial of synthetic salmon calcitonin in the treatment of acute pancreatitis. Scand J Gastroenterol (1979) 0.90
Beer and wine but not whisky and pure ethanol do stimulate release of gastrin in humans. Digestion (1983) 0.88
Novel generation of hormone receptor specificity by amino terminal processing of peptide YY. Biochem Biophys Res Commun (1992) 0.88
Stimulation of pancreatic secretion of enzymes by acute hypercalcaemia in man. Eur J Clin Invest (1973) 0.88
Altered postprandial motility in chronic pancreatitis: role of malabsorption. Gastroenterology (1997) 0.88
[Magnesium and calcium in duodenal juice: secretion pattern in chronic pancreatitis and in primary hyperparathyroidism (author's transl)]. Klin Wochenschr (1974) 0.88
Effects of ethanol on free coenzyme A, free carnitine and their fatty acid esters in rat liver. Biochim Biophys Acta (1970) 0.87
[Demographic and social characteristics of patients with Crohn disease in an urban area. A study with neighborhood hospital controls]. Z Gastroenterol (1985) 0.87
Detection of cholecystokinin-58 in human blood by inhibition of degradation. Am J Physiol (1987) 0.87
Visualization of Surfactants on Nanostructured Palladium Clusters by a Combination of STM and High-Resolution TEM. Science (1995) 0.87
Action of ethanol on gastrin release in the dog. Dig Dis Sci (1984) 0.87
Bone loss in patients with inflammatory bowel disease is less than expected: a follow-up study. Scand J Gastroenterol (1999) 0.86
Delivery and fate of oral mesalamine microgranules within the human small intestine. Gastroenterology (1995) 0.86
Molecular variants of cholecystokinin after endogenous stimulation in humans: a time study. Am J Physiol (1990) 0.86
Expression of insulin-like growth factor binding proteins and collagen in experimental colitis in rats. Eur J Gastroenterol Hepatol (2001) 0.86
Characterization of two forms of peptide YY, PYY(1-36) and PYY(3-36), in the rabbit. Peptides (1994) 0.85
Feedback regulation of human pancreatic secretion. Effects of protease inhibition on duodenal delivery and small intestinal transit of pancreatic enzymes. Gastroenterology (1990) 0.85
[Diagnosis and therapy of ulcerative colitis--results of an evidence-based consensus conference of the German Society of Digestive and Metabolic Diseases]. Z Gastroenterol (2001) 0.85
C-509T polymorphism in the TGFB1 gene promoter: impact on Crohn's disease susceptibility and clinical course? Immunogenetics (2001) 0.85
Diagnostic dilemma in pancreatic lymphoma. Case report and review. Int J Pancreatol (1997) 0.85
Duodenal and ileal nutrient deliveries regulate human intestinal motor and pancreatic responses to a meal. Am J Physiol (1997) 0.85
Fecal bile acid excretion pattern in cholecystectomized patients. Dig Dis Sci (1986) 0.84
Fecal bile acid excretion pattern in colonic cancer patients. Dig Dis Sci (1985) 0.84
Alcohol and cigarette smoking and the risk of colorectal adenomas. Dig Dis Sci (2000) 0.84
Mortality in elderly patients with acute renal failure. Ren Fail (1996) 0.84
Differential sensitivity of rat exocrine and endocrine pancreas to cyclosporine. Transplantation (1988) 0.84
Colorectal adenomas and diet: a case-control study. Colorectal Adenoma Study Group. Dig Dis Sci (2001) 0.84
Comparison of the small bowel motor response to solid and liquid meals in man. Digestion (1997) 0.84
Effects of secretin and cholecystokinin on motor activity of human jejunum. A radiotelemetering study of jejunal motility during secretin and cholecystokinin intravenous infusion. Digestion (1975) 0.83
[The influence of low temperature and storage time on some histochemically demonstrable enzyme activities in liver, kidney and jejunum of the rat]. Histochemie (1969) 0.83
Glucose-dependent insulinotropic action of cholecystokinin octapeptide in the isolated perfused rat pancreas. Digestion (1983) 0.82
Possible mode of action of 5-aminosalicylic acid. Dig Dis Sci (1987) 0.82
Inhibition of human gastric secretion by intragastrically administered calcitonin. Digestion (1980) 0.82
Effect of prolonged infusion of maximal and supramaximal doses of pancreozymin on pancreatic enzyme secretion in the rat--exhaustion or inhibition? Pflugers Arch (1976) 0.82
[Inhibitory effect of glucagon on human pancreatic secretion]. Verh Dtsch Ges Inn Med (1972) 0.82
RUDER--a prospective, two-year, multicenter study of risk factors for duodenal ulcer relapse during maintenance therapy with ranitidine. RUDER Study Group. Dig Dis Sci (1994) 0.82
Characterization of the major form of cholecystokinin in human intestine: CCK-58. Am J Physiol (1990) 0.81
Peptide YY inhibits exocrine pancreatic secretion in isolated perfused rat pancreas by Y1 receptors. Pancreas (1995) 0.81
Comparison of clearance and metabolism of infused cholecystokinins 8 and 58 in dogs. Gastroenterology (1993) 0.81
[Pathogenesis of alcohol-induced fat incorporation into the liver]. Klin Wochenschr (1971) 0.81
Factor XIII modulates intestinal epithelial wound healing in vitro. Scand J Gastroenterol (1999) 0.81
[Amyloidosis in Crohn disease. Case reports and review of the literature]. Med Klin (Munich) (1989) 0.81
[Intestinal protein-losing syndrome in malignant melanoma with gastrointestinal tract involvement]. Internist (Berl) (1970) 0.81
Large bowel cancer risk in cholelithiasis and after cholecystectomy. Postmortem study. Digestion (1988) 0.80
[Primary hyperparathyroidism and exocrine function of the pancreas. Disturbances of the enzyme and electrolyte secretion in the duodenal juice during a secretin-pancreozymin test]. Klin Wochenschr (1970) 0.80
Pancreatic secretory response to intravenous caerulein and intraduodenal tryptophan studies: before and after stepwise removal of the extrinsic nerves of the pancreas in dogs. Gastroenterology (1989) 0.80
Modulation of human periodic interdigestive gastrointestinal motor and pancreatic function by the ileum. Pancreas (1993) 0.80
Fecal bile acids in patients with adenomatous polyps of the colon. Case-control study. Digestion (1986) 0.80
[Studies on the substitution therapy with pancreatic enzyme preparations]. Med Welt (1969) 0.80